Skip to content

Clinical trials

Cardiomyopathy, Hypertrophic trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Country / region: Brazil Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20211
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Enrolling by invitation1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cytokinetics2
Bristol-Myers Squibb1
Hospital do Coracao1
Instituto de Cardiologia do Rio Grande do Sul1
Lexicon Pharmaceuticals1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic7
Arrhythmogenic Right Ventricular Dysplasia1
Brugada Syndrome1
Cardiomyopathy, Dilated1
Cardiomyopathy, Restrictive1
Death, Sudden, Cardiac1
Ehlers-Danlos Syndrome, Type IV1
Hyperlipoproteinemia Type II1
Loeys-Dietz Syndrome1
Long QT Syndrome1

Trials

Showing 51 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.